Tag: Motley Fool

  • Top brokers name 3 ASX shares to buy today

    Clock showing time to buy, ASX 200 shares

    Many of Australia’s top brokers have been busy adjusting their financial models again, leading to the release of a large number of broker notes this week.

    Three broker buy ratings that have caught my eye are summarised below. Here’s why brokers think these ASX shares are in the buy zone:

    Afterpay Ltd (ASX: APT)

    According to a note out of Morgan Stanley, its analysts have retained their overweight rating and $120.00 price target on this payments company’s shares. The broker notes that the RBA has indicated that it will allow the company to prevent retailers imposing a surcharge when shoppers use its service. This, together with the prospects of lower debit card fees, is being seen as a big positive for Afterpay. The Afterpay share price is trading at $98.01 on Tuesday.

    Estia Health Ltd (ASX: EHE)

    A note out of Macquarie reveals that its analysts have upgraded this aged care operator’s shares to an outperform rating with a $1.95 price target. While Macquarie expects near term trading conditions to remain uncertain, it notes that government funding could give the sector a boost. In addition to this, the broker likes the company due to its solid balance sheet and robust earnings. The Estia Health share price is fetching $1.75 this afternoon.

    Metcash Limited (ASX: MTS)

    Analysts at Citi have retained their buy rating and lifted the price target on this wholesale distributor’s shares to $4.00. This follows the release of a stronger than expected first half result earlier this week. Looking ahead, the broker believes that its Hardware business can drive growth over the medium term. And while it expects Food sales to moderate, this hasn’t stopped the broker from upgrading its earnings forecasts for the next couple of years. The Metcash share price is trading at $3.46 today.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of AFTERPAY T FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post Top brokers name 3 ASX shares to buy today appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/37JJOfj

  • Why the Tinybeans (ASX:TNY) share price is soaring 13% higher today

    tiny asx share price growth represented by little girl looking surprised

    Tinybeans Group Ltd (ASX: TNY) shares are soaring higher today following the company’s release of a positive trading update. At the time of writing, the Tinybeans share price is up 13.1% to $1.38. In earlier trade, Tinybeans shares reached as high as $1.43 before retracing slightly.

    What’s driving the Tinybeans share price higher?

    Investors are today driving the Tinybeans share prive higher after the company updated the market with a forecast record performance for the second quarter of FY21.

    According to the release, Tinybeans advised it saw strong trading conditions in October and November, with December remaining favourable.

    Revenue for the end of the second quarter is projected to be around $3 million. This represents a 146% increase on FY20’s second quarter revenue and a 24% rise above the prior quarter.

    The company said premium revenue will reach $280,000, which will reflect a 10% gain on the second quarter of FY20. Total paid subscriptions are expected to reach 23,000.

    Reaching over 4.6 million people, monthly active users are forecast to rise a massive 260% over the prior corresponding period, and 15% on the FY21 first quarter result.

    Complimenting the robust result, Tinybeans highlighted its advertising wins from both new and existing customers. These include contracts from major retailers Walmart Inc (NYSE: WMT) and Apple Inc (NASDAQ: AAPL).

    Further strengthening the company’s balance sheet, Tinybeans anticipates receiving $3 million in cash receipts for the second quarter. This represents a 40% lift on the previous period. The company estimates its cash balance will be around $4.2 million at the end of the quarter, which includes a cash burn of $400,000.

    What did the CEO say?

    Tinybeans CEO Mr Eddie Geller was excited to deliver the strong results. He said:

    After a successful Q1-FY21, we are absolutely thrilled to have such a strong follow up by delivering another record quarter.

    Metrics are up across all key business drivers. From monthly active users, to revenues to cash. The Company is forging ahead in executing the strategy to build the number one digital parenting platform and drive multiple complementary revenue streams.

    This is a testament to the team and the value proposition to parents and brands. This has set us up for an even better 2021 given the exciting product roadmap ahead.

    About the Tinybeans share price

    The Tinybeans share price has been climbing higher since the middle of August. Shareholders who bought the company’s share at that time would now be sitting on gains of around 80% over just a few months.

    Tinybeans shares reached a 52-week high of $2.90 in January and a 52-week low of 51 cents in March.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and recommends Apple. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Tinybeans Group Ltd. The Motley Fool Australia has recommended Apple and Tinybeans Group Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post Why the Tinybeans (ASX:TNY) share price is soaring 13% higher today appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/3gz2pyz

  • Citigroup downgrades these ASX mining stocks after a big rally

    Downgrade ASX stocks

    Analysts may be revising up their valuations for ASX miners but the sector’s big recent run prompted Citigroup to cut its recommendation on some stocks.

    The commodity that has been leading the charge higher is iron ore as the Chinese economy rebounds solidly from the COVID‐19 mayhem.

    Other metals have also performed well as confidence about global growth got a boost with positive vaccine news.

    Good news priced in

    Analysts are left scrambling to upgrade their valuations for ASX miners, but this may not be enough to keep some ASX stocks in the good books.

    Citigroup increased its price targets across the board for ASX miners. But it doesn’t believe there’s significant upside from current prices for most hard commodities, including copper, iron ore, aluminium and gold.

    “Global Mining is up 30% in USD terms in the last month given a supportive macro backdrop and equity rotation into value,” said Citi.

    “So, on DCF [discounted cash flow] it’s harder to find value using Citi LT [long-term] prices. For the large cap miners dominated by iron ore, FCF [free cash flow] generation is strong so dividends remain a key theme for us.”

    Fortescue share price downgraded after hitting record

    But with the Fortescue Metals Group Limited (ASX: FMG) share price racing to a record high, its strong FCF yield wasn’t enough to save it from a downgrade.

    Citi cut its rating on the stock to “neutral” from “buy” even as it lifted its price target to $21 from $18.50 a share.

    Other ASX miners that got downgraded

    Fortescue isn’t the only one that got a chop. The broker also downgraded the Champion Iron Ltd (ASX: CIA) share price to “sell” from “neutral” with a new target price of $4.40 a share, up from $3.35.

    But the downgrades couldn’t cool investors’ enthusiasm for iron ore miners. The Fortescue share price jumped 1% to $21.67, while the Champion Iron share price gained 1.6% to $5.16 during lunch time trade.

    Outside of iron ore, the Western Areas Ltd (ASX: WSA) share price got lowered by Citi to “neutral” from “buy” as the nickel miner is trading too close to the broker’s price target of $2.65 a share.

    Top ASX mining stocks to buy for 2021

    On the flipside, Citi’s top picks in the mining sector include the Rio Tinto Limited (ASX: RIO) share price.

    Other ASX mining stocks that Citi favours are the South32 Ltd (ASX: S32) share price and Alumina Limited (ASX: AWC) share price.

    Looking For Bargain Buys? These Cheap Stocks Could Be Just What You’re After (FREE REPORT)

    Scott Phillips has released a FREE stock report revealing 5 stocks that he believes are WAY undervalued by the market at these current prices.

    Scott thinks these 5 stocks are a ‘must consider’ for any savvy investor.

    Don’t miss out! Simply click the link below to grab your free copy and discover Scott’s 5 bargain stocks now.

    Click Here For Your Free Stock Report

    More reading

    Motley Fool contributor Brendon Lau owns shares of Rio Tinto Ltd. and South32 Ltd. Connect with me on Twitter @brenlau.

    The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post Citigroup downgrades these ASX mining stocks after a big rally appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/3mZaEq7

  • ASX stock of the day: Australian Primary Hemp (ASX:APH) shares surge 40% after open

    marijuana leaf with upward facing arrow

    The Australian Primary Hemp Ltd (ASX: APH) share price had an incredible start to the trading day this morning.

    The company’s shares closed at 38 cents a share yesterday afternoon, and opened at the same price this morning. However, the Primary Hemp share price took off soon after, rising as high as 52 cents a share just before 11 am. That rise represents a gain of 40% on the opening price.

    Primary Hemp shares have cooled off somewhat since, and are trading at 39 cents a share at the time of writing, up a still-respectable 4%. The current share price puts Australian Primary Hemp shares close to 130% up year to date.

    So what is this seemingly volatile company? And why are the shares going gangbusters today?

    What is Australian Primary Hemp?

    As you might have imagined, Australian Primary Hemp is one of Australia’s largest producers of home-grown hemp. If you aren’t familiar with hemp, it is a plant in the cannabis genus. However (before you call the police on this company), note that hemp does not meaningfully produce the psychoactive chemicals as its illicit botanical cousins do. As such, hemp plants have been legalised in Australia for commercial purposes since 2017.

    The Hemp plant produces fibres in a similar vein to cotton plants, which make it a good source of clothing materials and similar applications, such as rope making.

    But Australian Primary Hemp instead focuses on the nutritional benefits of hemp, of which there are apparently many. The company tells us that hemp is a plentiful source of protein, dietary fibre, amino acids, omega 3 and 6 and magnesium, amongst other nutrients.

    Australian Primary Hemp is especially focused on the use of the hemp seed, stating that, “this super seed contains the essential nutrients, vitamins and minerals for human function and has long been recognised for its nutritious value as one of China’s five ancient grains”.

    The company sells a range of hemp-derived products under the Australian Primary Hemp brand. These include hemp oil, hemp protein powder, hemp flour, and unprocessed hemp seeds. It even sells hemp-based hand sanitiser. It also markets these products, as well as a range of snack bars, under a premium ‘Mt. Elephant’ brand.

    Why is the share price blazing new highs today?

    The cause of today’s wild share market performance on the Australian Primary Hemp share price is not immediately obvious. There have been no price-sensitive announcements made to the ASX in December at all so far, with the last update coming out almost 3 weeks ago on 20 November.

    It is worth noting that this announcement outlined a very positive development for the company. It discussed how Mt. Elephant products are soon to be stocked in 7-11 convenience stores around the country, which was announced a few days earlier.

    However, if we dig a little deeper on today’s market moves, something interesting comes to light. ASX data shows that this company’s average trading volume is 12,831 shares per day. However, on this particular day, 586,712 shares have changed hands. And that’s with some hours left as well.

    ASX data shows that a significant chunk of the company’s shares (around 40,000) were bought this morning just after open, and an even bigger chunk (close to 60,000) were offloaded soon after. The data also shows significant selling dominating over the rest of the day so far.

    Small-cap shares like this one can be vulnerable to large buy or sell orders in terms of volatility. Could this be behind the massive swings we have seen in the Australia Primary Hemp share price today?

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post ASX stock of the day: Australian Primary Hemp (ASX:APH) shares surge 40% after open appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/3oGyKGJ

  • ASX mining shares boosted today after broker upgrades

    A happy miner tips his hard hat, indicating good ashare price results for ASX mining stocks

    ASX mining shares were given a boost today, on news that Goldman Sachs analysts have upgraded the broker’s iron ore and copper price forecasts, and raised the target prices for some big miners. 

    Which shares were upgraded

    Goldman Sachs has upgraded its target prices for the big three mining companies: BHP Group Ltd (ASX: BHP)Rio Tinto Limited (ASX: RIO), and Fortescue Metals Group Limited (ASX: FMG).

    The broker said BHP was the best share to play the strong copper price, and lifted the miner’s earnings estimates for the 2021 and 2022 financial years by 26% and 37% respectively.

    Goldman lifted its price target for BHP by 8% to $45, and rated the shares a “buy”.

    The broker also raised Rio Tinto’s earnings forecasts for 2021 and 2022 by 48% and 49% respectively, lifting its share price target 11% to $108.10 a share. The broker rated Rio shares “neutral”.

    Meanwhile, Fortescue Metals’ earnings for the two years were raised 35% and 71%, and its price target increased by 18% to $20.10 a share. The broker rated Fortescue shares “neutral”.

    Higher iron ore and copper price forecasts

    Goldman said the upgrades were underpinned by its bullish forecasts for the iron ore and copper prices.

    The broker lifted its 2021 iron ore price forecast up 33% to US$120 a tonne.

    Longer range forecasts for 2022 and 2023 were also raised by 27% and 11% to US$95 a tonne and US$80 a tonne respectively. 

    Iron ore has recently rallied to US$148 a tonne after the Brazilian producer Vale SA cut its production guidance. The Brazilian miner is having ongoing production problems after an accident at one of its mines. The company has said that it was unlikely to be back at full output before the end of 2022.

    Meanwhile, Goldman also lifted its copper price forecast for 2021 by 18% to US$3.91 a pound, and by 23% to US$4.17 a pound in 2023.

    Iron ore supply to China

    The upgrades today have given further support for Australia’s iron ore exporters to China, who experts said would not be significantly impacted by the recent political spat with Beijing.

    Experts said that China has few alternatives to replace Australian iron ore imports, with more than half of iron ore supply globally shipped from this country. At best, China could only get 56% of its current volumes if it completely cut off Australia – according to analysts. This has so far undermined Beijing’s ability to coerce Australia economically.

    Share price movements today

    At the time of writing, the BHP share price is up 0.77% to $42.58, and the Rio Tinto share price is almost unchanged at $115. Meanwhile, Fortescue Metal share price has lifted 0.98% to $21.67.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Motley Fool contributor Eddy Sunarto owns shares of BHP Billiton Limited. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post ASX mining shares boosted today after broker upgrades appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/37Qflfo

  • Why Abacus, Emerge Gaming, Jumbo, & Woodside shares are dropping lower

    red chart with downward arrow

    In afternoon trade the S&P/ASX 200 Index (ASX: XJO) has followed the lead of U.S. markets and is pushing higher again. The benchmark index is currently up 0.7% to 6,735.7 points.

    Four shares that have failed to follow the market higher today are listed below. Here’s why they are dropping lower:

    Abacus Property Group (ASX: ABP)

    The Abacus share price is down 4.5% to $2.96. This follows the completion of its institutional entitlement offer. The property company raised approximately $356 million at a price of $2.90 per new share. This represents a 6.5% discount to its last close price. The proceeds will be used to repay debt and increase its acquisition capacity for continued growth over the medium term.

    Emerge Gaming Ltd (ASX: EM1)

    The Emerge Gaming share price has crashed a massive 43.5% lower to 5.8 cents. Investors have been heading to the exits in their droves after the gaming technology company revealed just 25,674 paid subscriptions to its MIGGSTER platform. In October the company claimed to have over 6 million pre-registrations for the platform. This means it has so far converted just 0.43% of its pre-registrations.

    Jumbo Interactive Ltd (ASX: JIN)

    The Jumbo Interactive share price has sunk 7% lower to $12.81. This morning analysts at UBS initiated coverage on the company with a neutral rating and $14.10 price target. The broker notes that Tabcorp Holdings Limited (ASX: TAH) appears to be winning market share in the local online market. It intends to wait for the trend to stabilise before considering a change to its rating.

    Woodside Petroleum Limited (ASX: WPL)

    The Woodside share price is down almost 2% to $22.71. The catalyst for this decline appears to have been a broker note out of Ord Minnett. This morning the broker downgraded its shares to a hold rating with a $23.80 price target. Its analysts note that the energy producer’s CEO has announced plans to retire next year. The broker was surprised by this and notes that it comes at a critical time.

    This Tiny ASX Stock Could Be the Next Afterpay

    One little-known Australian IPO has doubled in value since January, and renowned Australian Moonshot stock picker Anirban Mahanti sees a potential millionaire-maker in waiting…

    Because ‘Doc’ Mahanti believes this fast-growing company has all the hallmarks of genuine Moonshot potential, forget ‘buy now pay later’, this stock could be the next hot stock on the ASX.

    Doc and his team have published a detailed report on this tiny ASX stock. Find out how you can access what could be the NEXT Afterpay today!

    Returns as of 6th October 2020

    More reading

    James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. recommends Jumbo Interactive Limited. The Motley Fool Australia owns shares of and has recommended Jumbo Interactive Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post Why Abacus, Emerge Gaming, Jumbo, & Woodside shares are dropping lower appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/2JDjhs5

  • Why the Resonance Health (ASX:RHT) share price is shooting 39% higher today

    increase in asx medical software share price represented by doctor making excited hands up gesture

    The Resonance Health Limited (ASX: RHT) share price is shooting the lights out today. This comes after the company announced it has received a 510(k) clearance from the United States Food and Drug Administration (FDA) for its HepaFat-AI software.

    At the time of writing, the Resonance Health share price is up 38.7% to 21.5 cents. In comparison, the All Ordinaires Index (ASX: XAO) is up 0.7% to 6,969 points.

    What’s driving the Resonance Health share price?

    The Resonance Health share price is surging today following the company’s positive FDA clearance announcement.

    According to Resonance Health, the FDA has cleared the pathway for the company to begin commercialisation for its HepaFat-AI technology.

    HepaFat-AI is a medical imagining technology that uses artificial intelligence to assess liver fat. The software analyses volumetric liver fat fraction (VLFF), proton density fat fraction (PDFF), and steatosis grade in individuals who suffer from fatty liver disease.

    Once screened, a doctor or physician is able to explain the results to the patient which can, in turn, support them in weight loss management. In addition, the report can also evaluate if a person has a suitable liver for becoming a donor.

    It is estimated that up to 30% of the world’s population suffers from non-alcoholic fatty liver disease (NAFLD). This represents up to 2.3 billion people who face the possible risk of developing liver damage and fibrosis.

    In financial terms, Resonance reported that over the next 10 years, the increasing incidence of NAFLD could cost the healthcare system $1 trillion in the United States alone. Furthermore, another 334 billion euros could expected to be sunk into treating the disease across Germany, France, Italy and the United Kingdom.

    The company said that while there are currently a number of ways to measure liver fat, comparing results from different scan types is very difficult, with results highly variable. HepaFat-AI aims to improve on traditional testing measures by delivering a standardised assessment that allows for accurate comparisons across various scanner types. The company also highlighted that steatosis grading can be time consuming using other methods, however its software has automated the process, allowing for results to be produced much faster.

    Resonance Health stated that it intends to pursue multiple channels to get HepaFat-AI to market.

    What did management say?

    Resonance Health CEO Ms Alison Laws commented on HepaFat-AI’s applications and the result from the FDA. She said:

    The use of artificial intelligence in medical image review and assessment has the ability to support and transform radiology via the delivery of rapid, reproducible results whenever needed. HepaFat-AI, the Company’s second AI-based medical device to gain clearance from the FDA, will enable radiologists to report three key parameters (VLFF, PDFF, and steatosis grade) in patients in this significant and ever-increasing addressable market.

    The clearance from the FDA to assess and report all three metrics in HepaFat-AI patient reports is an outstanding result for the Company and an outstanding result for the product itself.

    Resonance Health share price summary

    The Resonance Health share price has been on the rise since late September, delivering more than a 50% gain to shareholders. Resonance shares are, however, still 17% lower since the beginning of the year.

    The Resonance share price reached a 52-week high of 28 cents in January and a 52-week low of 9.2 cents in March.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Resonance Health Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post Why the Resonance Health (ASX:RHT) share price is shooting 39% higher today appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/3oywPnp

  • About to invest in Tesla? Consider this battery stock instead

    This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

    battery shares represented by lots of electric vehicles driving along road

    This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

    Once the stuff of futuristic movies, the electrification of the automobile industry seems all but inevitable today. While Tesla Inc (NASDAQ: TSLA) receives most of the attention from analysts and investors, there seems to be a new headline every day about an automaker touting its upcoming electric vehicle, or EV. Investors wishing to participate in this new ‘gold-rush’ may be forgiven for hesitating to pick winners from losers from the vast offering at hand. One way to participate in this trend may be to invest instead in the companies making ‘picks and shovels’ rather than in the ‘gold prospectors’ themselves.

    The one thing every EV needs more of

    That would be range, or how long an EV can go on a full charge. As consumers consider buying an EV, range becomes key for at least two reasons: First, since there aren’t as many EV chargers as there are gas stations, consumers experience ‘range anxiety,’ or the idea that they can get stuck in the middle of nowhere without a way to recharge.

    Second, recharging an EV takes a lot longer than filling up. So, the longer the range, the bigger the market for, or the number of people who may buy, that EV. Today, range is arguably the most objective differentiator between a Tesla and all other EVs in the market.

    Battery technology determines range. But battery technology is key in another important way: It is what makes EVs more expensive than equivalent gasoline cars today. 

    Imagine having an EV that could go seven hours between charges — to then recharge in about 15 minutes. Now imagine you could buy this EV for about the same price as a gasoline car. This is what QuantumScape (NYSE: QS) claims its product will deliver to the EV industry.

    A solid story

    Many companies have worked on solid-state batteries over the years — with nearly all of them failing to make a commercially viable product. QuantumScape itself has been working on lithium-metal batteries, a type of solid-state battery, since 2010. The company claims its batteries will store over 80% more energy than existing lithium-ion competitors while reducing costs substantially. To put this into perspective, Tesla recently announced breakthroughs in battery manufacturing that should deliver up to 54% additional range in about two years.

    80% improvement at a lower cost are tall claims for any product. However, several things set QuantumScape apart. For one, it has attracted investment from a number of high-caliber investors: It received $300 million from Volkswagen (OTC: VWAGY), the largest automaker in the world, and arguably one of the most committed to leading the EV transition, as well as venture capitalists such as Bill Gates and Kleiner Perkins. At the end of November 2020, it executed a successful reverse merger with Kensington Capital Acquisition Corp. (NYSE: KCAC), a SPAC, including money from legendary investor John Doerr and Tesla co-founder JB Straubel, just to name a few. The merger put the company’s enterprise value — or the total value of its stock, cash, and debt — at $3.3 billion. And after the merger, the combined entity has achieved a market capitalisation (the value of all of its outstanding stock times its price) of over $14 billion. 

    The company’s relationship with Volkswagen gives it another leg up: A large, marquee customer. By 2029, Volkswagen plans to sell over 22 million vehicles across about 70 EV models. While QuantumScape expects Volkswagen to be the first company to commercialize its products, it plans on selling its batteries to many other automakers.

    Its executive team is no less impressive, with a number of well-known Silicon Valley entrepreneurs, and even the chair of Stanford’s mechanical engineering department, on its executive team and board.

    What’s the catch?

    While Volkswagen has successfully tested initial versions of QuantumScape’s batteries, the company still has a lot of work to do to further develop key parts of the technology and turn them into a product that can be manufactured affordably and at scale. The company’s recent merger and listing provided it with fresh cash — to the tune of $700 million — that it will put to work to do just that.

    This also means, however, that the company won’t have a product to sell, or any meaningful revenue, for a while — until at least 2024, actually. So, significant stock appreciation may take a few years and will be determined by the company’s progress toward product development and manufacturing milestones rather than by traditional financial metrics such as revenue, free cash flow, or gross margins.

    Is QuantumScape worth the risk? Investing in an early-stage company, or a start-up is mostly about maximizing the company’s likelihood of success while limiting the risk.

    As far as potential, QuantumScape certainly checks most of the boxes: The team that led the SPAC and now leads the merged company reads like a who’s-who of technological innovation, industry experience, execution, and investing savvy. The company’s product promises much-needed disruption in a young industry with lots of momentum and impressive growth potential. And while revenue is still several years away, the company already has a very large, marquee customer, and is valued at roughly one times 2027 estimated revenue. So, assuming the company hits its projected milestones, its stock has a ton of upside.

    As far as limiting risk, however, Fools considering an investment in QuantumScape should probably take a conservative approach, hedge their bets, and avoid putting all of their hard-earned dollars on a small handful of high-risk/high-reward stocks.

    This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Luis Morales owns shares of QuantumScape and Tesla. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and recommends Tesla. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post About to invest in Tesla? Consider this battery stock instead appeared first on The Motley Fool Australia.

    This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

    from The Motley Fool Australia https://ift.tt/39RGFfV

  • Why the Creso Pharma (ASX:CPH) share price is rocketing 96% higher today

    asx share price increase represented by golden dollar sign rocketing out from white domes

    The Creso Pharma Ltd (ASX: CPH) share price has continued its remarkable run on Wednesday.

    At the time of writing, the cannabis company’s shares are up a massive 96% to a 52-week high of 46 cents.

    This means the Creso Pharma share price has now rocketed an incredibly devilish 666% since this time last week.

    This takes the company’s market capitalisation beyond $300 million.

    Why is the Creso Pharma share price rocketing higher?

    There are a couple of catalysts for the stunning rise in the Creso Pharma share price.

    The first is news over the last few days that the UN has announced a landmark decision to reclassify cannabis as a less dangerous drug and the US House of Representatives has voted to decriminalise cannabis. 

    Co-founder and Director, Boaz Wachtel, commented: “Creso is very well positioned to capitalise on opportunities arising from the market in the USA, including expanding distribution of its existing cannabis products through the scale up its operations in Canada and Switzerland. As a listed vehicle with access to capital, Creso is also an attractive partner for merger and acquisition opportunities, and, following the appointment of Canopy Growth Founder, Bruce Linton to Creso earlier this year, the Company looks forward to exploring such opportunities for the benefit of its shareholders.”

    Canada expansion.

    Also giving the company’s shares a boost was the release of an announcement this morning.

    Creso Pharma has announced plans to expand into Canada’s largest recreational market. This follows the receipt of orders worth ~C$230,000 from the Province of Ontario and a maiden purchase order from the Yukon Liquor Corporation.

    The company notes that these orders open potential opportunities for new Canadian markets in Ontario and the Yukon, which have recorded combined sales for recreational cannabis of over C$300 million for year to date.

    Management commented: “We are proud to announce that Mernova has been chosen to become part of a very select group of licensed producers with cannabis products for sale in the Yukon. This is a major achievement for us, and we expect growth to continue across Canada and, with our pending entry into Ontario, Canada’s largest recreational market, we expect rapid growth to continue.”

    Creso Pharma placement.

    Interestingly, prior to the Creso Pharma share price rocketing higher this month, the company had announced a $6 million placement comprising 250 million shares at an issue price of just 2.4 cents.

    Based on a share price of 46 cents, those 250 million shares now have a value of $115 million.

    Unfortunately for those that were due to take part in this placement, the vote to approve this placement hasn’t happened yet and they’ve missed out on these stellar gains.

    Though, they still stand to benefit from a significant discount if shareholders approve the issue on 23 December.

    Last month, Creso explained: “The quantum of future placement shares to be issued is based on a maximum amount to be raised of $6,000,000, at an issue price which will not be less than 75% of the 15 trading day VWAP immediately before the date on which the issue price is agreed by the Company.”

    A 75% discount to the current share price would be approximately 11.5 cents per share.

    Though, it wouldn’t be at all surprising if the company scrapped this placement and launched a much larger capital raising to take advantage of this significant share price increase.

    This Tiny ASX Stock Could Be the Next Afterpay

    One little-known Australian IPO has doubled in value since January, and renowned Australian Moonshot stock picker Anirban Mahanti sees a potential millionaire-maker in waiting…

    Because ‘Doc’ Mahanti believes this fast-growing company has all the hallmarks of genuine Moonshot potential, forget ‘buy now pay later’, this stock could be the next hot stock on the ASX.

    Doc and his team have published a detailed report on this tiny ASX stock. Find out how you can access what could be the NEXT Afterpay today!

    Returns as of 6th October 2020

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post Why the Creso Pharma (ASX:CPH) share price is rocketing 96% higher today appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/2VY1SfW

  • Washington H. Soul Pattinson (ASX:SOL) share price rises 2% after upbeat AGM

    Investor touching a screen with a smiley face icon on it

    The Washington H. Soul Pattinson and Co. Ltd (ASX: SOL) share price has lifted 2% this morning following its annual general meeting (AGM).

    The investment house’s shares are trading at $29.59 at the time of writing, up by 58 cents.

    Highlights from the AGM

    Washington H. Soul Pattinson provided an update on the first four months to 30 November.

    The company says that its financial services portfolio is up 16%, while its pharmaceutical portfolio is also up by 10% during this period.

    Its base metals investments are also performing well this month, with copper and zinc prices increasing by 20% and 21% respectively.

    Meanwhile, the recovery in thermal coal price of up to 33% is underpinning its stake in New Hope Corporation Limited (ASX: NHC).

    In terms of outlook, Washington H. Soul Pattinson says that cash generation from the portfolio remains strong to support future dividends, while liquidity is readily available for new opportunities and investments.

    Disappointing FY20 

    Earlier in the year, the company had reported a 44% full-year decrease in its underlying net profit before tax (NPAT) to $169.7 million. 

    The company said that the fall in profits were due to New Hope experiencing falling coal prices, as well as lower coal production from its Acland mines.

    The disappointing results were also caused by COVID-19-related impact to its Brickworks Limited (ASX: BKW) building products business. 

    The Washington H. Soul Pattinson portfolio

    Washington H. Soul Pattinson says that over the last 20 years, its total shareholder return (TSR) has outperformed the market by 14.3% per annum.

    During this 20-year period, an investment in Washington H. Soul Pattinson appreciated approximately 13.5 times, while an investment in the index increased by just 2.3 times.

    Washington H. Soul Pattinson says it is also the only company in the top 500 listed companies in Australia to have increased its dividend every year for the last 20 years, and that it hasn’t  missed paying dividends since listing in 1903.

    As of today, the company’s top investment is in its Telecommunications Portfolio, representing 35% of the overall portfolio. This is followed by investment in Brickworks, which makes up 25.5%. The stake in New Hope rounds up the top three, making up 10% of Washington H. Soul Pattinson’s portfolio.

    About the Washington H. Soul Pattinson share price in 2020

    The Washington H. Soul Pattinson share price has gained almost 40% this year, after dropping 20% in April. The share price is currently closing in on its 52-week high of $29.66. 

    The company commands a market cap of $6.95 billion.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Motley Fool contributor Eddy Sunarto has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Brickworks and Washington H. Soul Pattinson and Company Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post Washington H. Soul Pattinson (ASX:SOL) share price rises 2% after upbeat AGM appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/33XJ5pB